tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Valneva’s Stock: A Buy Rating Amid Overreaction and Promising Vaccine Prospects
RatingsValneva’s Stock: A Buy Rating Amid Overreaction and Promising Vaccine Prospects
4d ago
VALN
Valneva selloff on FDA suspension overdone, says H.C. Wainwright
PremiumThe Fly
Valneva selloff on FDA suspension overdone, says H.C. Wainwright
4d ago
VALN
Valneva price target lowered to $14 from $18 at Jefferies
PremiumThe Fly
Valneva price target lowered to $14 from $18 at Jefferies
4d ago
VALN
Valneva announces U.S. FDA’s decision to suspend license of IXCHIQ
PremiumThe Fly
Valneva announces U.S. FDA’s decision to suspend license of IXCHIQ
4d ago
VALN
Valneva SE (ADR) trading halted, news pending
PremiumThe Fly
Valneva SE (ADR) trading halted, news pending
7d ago
VALN
Valneva’s Promising Future: Buy Rating Backed by VLA15 Vaccine and Robust Portfolio
PremiumRatingsValneva’s Promising Future: Buy Rating Backed by VLA15 Vaccine and Robust Portfolio
10d ago
VALN
Valneva assumed with a Buy at H.C. Wainwright
Premium
The Fly
Valneva assumed with a Buy at H.C. Wainwright
10d ago
VALN
0OB3 Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
0OB3 Upcoming Earnings Report: What to Expect?
19d ago
Valneva signs development, manufacturing agreement with AGC Biologics
PremiumThe Fly
Valneva signs development, manufacturing agreement with AGC Biologics
1M ago
VALN
UK restricts use of Valneva chikungunya vaccine for safety review
PremiumThe Fly
UK restricts use of Valneva chikungunya vaccine for safety review
3M ago
VALN
Valneva drops 2% to $6.05 after UK restricts vaccine use
PremiumThe Fly
Valneva drops 2% to $6.05 after UK restricts vaccine use
3M ago
VALN
Valneva says IXCHIQ ‘well tolerated’ by children ages 1-11 years
PremiumThe Fly
Valneva says IXCHIQ ‘well tolerated’ by children ages 1-11 years
3M ago
VALN
Valneva’s Earnings Call: Growth Amid Challenges
PremiumCompany AnnouncementsValneva’s Earnings Call: Growth Amid Challenges
4M ago
Valneva price target lowered to $14 from $15 at Guggenheim
Premium
The Fly
Valneva price target lowered to $14 from $15 at Guggenheim
4M ago
VALN
Valneva says EMA started Ixchiq review after reports of SAEs
Premium
The Fly
Valneva says EMA started Ixchiq review after reports of SAEs
4M ago
VALN
Valneva’s Vaccine Approval and Strategic Partnerships Drive Buy Rating with Promising Financial Projections
PremiumRatings
Valneva’s Vaccine Approval and Strategic Partnerships Drive Buy Rating with Promising Financial Projections
5M ago
VALN
Valneva granted marketing authorization for Ixchiq in Brail
PremiumThe Fly
Valneva granted marketing authorization for Ixchiq in Brail
5M ago
VALN
Positive Outlook for Valneva Driven by Promising Vaccine Pipeline and Strategic Developments
PremiumRatings
Positive Outlook for Valneva Driven by Promising Vaccine Pipeline and Strategic Developments
5M ago
VALN
Valneva granted EC marketing authorization for Ixchiq vaccine
PremiumThe Fly
Valneva granted EC marketing authorization for Ixchiq vaccine
5M ago
VALN
Valneva’s Strategic Advancements and Promising Projections Drive Buy Rating with $17 Target
PremiumRatingsValneva’s Strategic Advancements and Promising Projections Drive Buy Rating with $17 Target
5M ago
VALN
Valneva renews sales agreement in connection with existing at-the-market program
Premium
The Fly
Valneva renews sales agreement in connection with existing at-the-market program
5M ago
VALN
Valneva to provide 40,000 IXCHIQ doses in France starting early April
Premium
The Fly
Valneva to provide 40,000 IXCHIQ doses in France starting early April
5M ago
VALN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >